Individuals with the metabolic syndrome, which is known to increase the risk of cardiovascular disease, and diabetes may also have an increased risk of vascular dementia, but not Alzheimer’s disease.

New research on the brain suggests that women unconsciously have a tougher time resisting their favorite foods than men do.

TZDs and exenatide have modest but beneficial effects on glycemic control and are relatively safe in regard to the adverse events studied. Which one produced the better results?

Randomized trials have demonstrated the efficacy of selected beta- blockers in systolic heart failure, but the comparative effectiveness of different beta-blockers in practice is poorly understood.

Survey finds communication gap between patients and physicians and other barriers are making weight loss difficult. Only 60% of physicians recommend weight loss to their diabetic patients.

More people are afraid of being in a plane crash, hit by lightning or bitten by a snake than developing diabetes, according to a recently announced American Diabetes Association survey. In 2007, 233,619 people died from diabetes and 491 died from aviation accidents.

Most times when we talk about teenagers and diabetes we are talking about type 1 patients, but with the large increase in adolescent cases of type 2 diabetes, all practitioners are likely to see these patients. Since there is not as much urgency with type 2 diabetes, parents often do …

Often our patients with diabetes have unexplained hypoglycemia and there seems to be no rhyme or reason as to why. Sheri Colberg, Ph.D., FACSM has the latest research on what happens to cause this. Read Exercise and Hypoglycemia: Their Effect on Hormonal Responses

Researchers have successfully induced human insulin-producing cells, known as beta cells, to replicate robustly in a living animal, as well as in the lab. The discovery not only could improve models and methods for studying diabetes, but also opens up new possibilities for treating the condition.

Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors or ARBs can slow rates of progression of diabetic nephropathy.